X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2468) 2468
humans (2022) 2022
interleukin-1beta - biosynthesis (1613) 1613
mice (1470) 1470
male (1301) 1301
inflammation (1100) 1100
immunology (1018) 1018
interleukin-1beta - metabolism (1012) 1012
cells, cultured (925) 925
female (865) 865
cytokines (834) 834
rats (727) 727
expression (696) 696
interleukin-1beta - genetics (686) 686
tumor necrosis factor-alpha - biosynthesis (679) 679
interleukin-1beta - pharmacology (618) 618
cell biology (601) 601
activation (593) 593
cell line (508) 508
interleukin-6 - biosynthesis (486) 486
mice, inbred c57bl (479) 479
biochemistry & molecular biology (472) 472
gene expression (446) 446
nf-kappa b - metabolism (437) 437
tumor necrosis factor-alpha - metabolism (409) 409
macrophages (399) 399
nf-kappa-b (389) 389
il-1β (378) 378
cells (373) 373
adult (351) 351
signal transduction (347) 347
interleukin-1beta - immunology (344) 344
gene-expression (341) 341
lipopolysaccharides - pharmacology (340) 340
middle aged (338) 338
research article (334) 334
macrophages - metabolism (330) 330
apoptosis (328) 328
pharmacology & pharmacy (325) 325
disease models, animal (316) 316
enzyme-linked immunosorbent assay (314) 314
mice, knockout (306) 306
cytokines - biosynthesis (301) 301
rna, messenger - genetics (297) 297
rats, sprague-dawley (288) 288
proteins (287) 287
macrophages - immunology (283) 283
research (280) 280
neurosciences (277) 277
tumor necrosis factor-alpha - genetics (273) 273
analysis (269) 269
reverse transcriptase polymerase chain reaction (267) 267
rna, messenger - metabolism (265) 265
signal transduction - drug effects (265) 265
inflammation - metabolism (258) 258
rna, messenger - biosynthesis (255) 255
rheumatology (249) 249
rodents (247) 247
inflammation - immunology (242) 242
nitric oxide - biosynthesis (241) 241
abridged index medicus (239) 239
medicine (238) 238
macrophages - drug effects (237) 237
tnf-alpha (236) 236
aged (235) 235
gene expression regulation - drug effects (235) 235
necrosis-factor-alpha (233) 233
anti-inflammatory agents - pharmacology (232) 232
oxidative stress (229) 229
interleukins (226) 226
rats, wistar (226) 226
interleukin-6 - metabolism (222) 222
blotting, western (221) 221
interleukin-1beta - antagonists & inhibitors (219) 219
multidisciplinary sciences (219) 219
physiological aspects (217) 217
gene expression regulation (216) 216
phosphorylation (216) 216
cell line, tumor (215) 215
up-regulation (215) 215
inhibition (212) 212
pathology (211) 211
mice, inbred balb c (207) 207
nitric oxide (207) 207
health aspects (206) 206
lipopolysaccharides (202) 202
tumor-necrosis-factor (200) 200
dose-response relationship, drug (199) 199
il-1 beta (196) 196
inflammation - pathology (196) 196
lipopolysaccharide (193) 193
nitric-oxide (190) 190
interleukin 1 (188) 188
immunohistochemistry (187) 187
inflammation mediators - metabolism (186) 186
science (186) 186
in-vitro (184) 184
caspase 1 - metabolism (182) 182
cytokine (182) 182
cyclooxygenase 2 - metabolism (181) 181
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3826) 3826
Chinese (35) 35
Japanese (29) 29
Russian (18) 18
Portuguese (7) 7
Spanish (2) 2
French (1) 1
German (1) 1
Italian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature communications, ISSN 2041-1723, 2011, Volume 2, Issue 1, p. 240
The immune system can both promote and suppress cancer. Chronic inflammation and proinflammatory cytokines such as interleukin (IL)-1 and IL-6 are considered... 
LUNG-CANCER | INTERFERON-INDUCIBLE PROTEIN-10 | NECROSIS IN-VIVO | PROGNOSTIC-FACTORS | INTERLEUKIN-1 RECEPTOR ANTAGONIST | IFN-GAMMA | MULTIDISCIPLINARY SCIENCES | CD4(+) T-CELLS | ADJUVANT THERAPY | CARCINOMA | EXPRESSION | Angiostatic Proteins - immunology | Immunohistochemistry | Neoplasms - metabolism | Interleukin-1alpha - immunology | Chemokine CXCL9 - biosynthesis | Tumor Microenvironment | Multiple Myeloma - immunology | Th2 Cells - immunology | Th1 Cells - immunology | CD4-Positive T-Lymphocytes - immunology | Chemokine CXCL10 - biosynthesis | Inflammation - metabolism | Interleukin-2 - immunology | Chemokine CXCL10 - immunology | Lymphoma, B-Cell - immunology | Interleukin-1beta - biosynthesis | Macrophages - immunology | Interleukin-12 - biosynthesis | Lymphoma, B-Cell - metabolism | Signal Transduction | Angiostatic Proteins - biosynthesis | CD4-Positive T-Lymphocytes - cytology | CD4-Positive T-Lymphocytes - metabolism | Interleukin-1beta - immunology | Chemokine CXCL9 - immunology | Inflammation - immunology | Macrophages - cytology | Mice, SCID | Multiple Myeloma - metabolism | Macrophages - metabolism | Multiple Myeloma - pathology | Animals | Neoplasms - immunology | Interferon-gamma - immunology | Interleukin-12 - immunology | Interleukin-6 - immunology | Lymphoma, B-Cell - pathology | Cell Line, Tumor | Interleukin-6 - biosynthesis | Interleukin-1alpha - biosynthesis | Mice | Interleukin-2 - biosynthesis | Neoplasms - pathology | Interferon-gamma - biosynthesis
Journal Article
Journal of neuroimmunology, ISSN 0165-5728, 2008, Volume 194, Issue 1-2, pp. 54 - 61
Abstract Interleukin (IL)-17-producing helper T cells may play a pivotal role in the pathogenesis of multiple sclerosis. Here, we examined the effects of IL-17... 
Neurology | Allergy and Immunology | EAE | Cytokine | IL-17 | Microglia | MS | cytokine | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | MULTIPLE-SCLEROSIS LESIONS | MESSENGER-RNA EXPRESSION | NEUROTROPHIC FACTOR | IMMUNOLOGY | NEUROSCIENCES | NERVE GROWTH-FACTOR | INTERLEUKIN-17 | NEURONAL DEATH | NITRIC-OXIDE | TNF-ALPHA | microglia | T-CELLS | Brain-Derived Neurotrophic Factor - genetics | Microglia - metabolism | Humans | Tumor Necrosis Factor-alpha - genetics | Interleukin-17 - physiology | Receptors, Interleukin-17 - genetics | Interleukin-17 - pharmacology | Interleukin-1beta - genetics | Interleukin-23 - genetics | RNA, Messenger - biosynthesis | Chemokine CXCL2 - genetics | Brain-Derived Neurotrophic Factor - biosynthesis | Interleukin-1beta - biosynthesis | Multiple Sclerosis - metabolism | Autocrine Communication | Nitric Oxide - biosynthesis | Cells, Cultured - drug effects | Interleukin-6 - genetics | Microglia - drug effects | Receptors, Interleukin-17 - biosynthesis | Glial Cell Line-Derived Neurotrophic Factor - biosynthesis | Glial Cell Line-Derived Neurotrophic Factor - genetics | Interleukin-17 - biosynthesis | Recombinant Proteins - pharmacology | Gene Expression Regulation - drug effects | Up-Regulation - drug effects | Animals | Interleukin-23 - biosynthesis | Interleukin-6 - biosynthesis | Cells, Cultured - metabolism | Chemokine CXCL2 - biosynthesis | Mice | Tumor Necrosis Factor-alpha - biosynthesis | Multiple sclerosis | Interleukins | T cells | Nitric oxide
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 04/2011, Volume 300, Issue 4, pp. 1418 - 1426
Post-myocardial infarction (MI), chemokine homing of inflammatory cells into the injured left ventricle (LV) regulates ventricular remodeling, in part by... 
CC chemokines | Inflammation | Matrix metalloproteinases | RECRUITMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | ANGIOGENESIS | MONOCYTE CHEMOATTRACTANT PROTEIN-1 | INCREASES | ISLET XENOGRAFTS | HEART | inflammation | PERIPHERAL VASCULAR DISEASE | MICE | matrix metalloproteinases | EXPRESSION | LEFT-VENTRICULAR FUNCTION | Myocardial Infarction - genetics | Macrophage Activation - genetics | Antigens, CD - biosynthesis | Mannose-Binding Lectins - biosynthesis | Receptors, CCR5 - genetics | Arginase - biosynthesis | Male | Lectins, C-Type - biosynthesis | Gene Deletion | Myocardial Infarction - pathology | Ventricular Remodeling - genetics | Female | Interleukin-1beta - biosynthesis | Receptors, Cell Surface - biosynthesis | Receptors, CCR5 - physiology | Procollagen - biosynthesis | Transforming Growth Factor beta1 - biosynthesis | HSP47 Heat-Shock Proteins - biosynthesis | Antigens, Differentiation, Myelomonocytic - biosynthesis | Macrophages - pathology | Ventricular Remodeling - physiology | Collagen Type I - biosynthesis | Macrophages - metabolism | Animals | Interleukin-6 - biosynthesis | Mice | Tumor Necrosis Factor-alpha - biosynthesis | Gene mutations | Physiological aspects | Genetic aspects | Research | Macrophages | Health aspects | Chemokine receptors | Heart attack | Risk factors | Integrative Cardiovascular Physiology and Pathophysiology
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 1524-4539, 2007, Volume 115, Issue 12, pp. 1599 - 1608
Background-Stroke is the second to third leading cause of death. Toll-like receptor 4 (TLR4) is a signaling receptor in innate immunity that is a specific... 
Infection | Cerebral ischemia | Stroke | Nitric oxide synthase | Inflammation | Metalloproteinases | Immune system | infection | CARDIAC & CARDIOVASCULAR SYSTEMS | LIPID-PEROXIDATION | FOCAL CEREBRAL-ISCHEMIA | metalloproteinases | stroke | NITRIC-OXIDE-SYNTHASE | MATRIX METALLOPROTEINASES | TUMOR-NECROSIS-FACTOR | TOLL-LIKE RECEPTOR-4 | MESSENGER-RNA | inflammation | cerebral ischemia | immune system | GENE-EXPRESSION | PERIPHERAL VASCULAR DISEASE | nitric oxide synthase | HEMATOLOGY | PATTERN-RECOGNITION RECEPTORS | INNATE IMMUNITY | Interferons - biosynthesis | Nitric Oxide Synthase Type II - biosynthesis | Oxidative Stress | Tumor Necrosis Factor-alpha - genetics | Nitrobenzenes - therapeutic use | Male | NF-kappa B - metabolism | Interleukin-1beta - genetics | Cyclooxygenase 2 - biosynthesis | Toll-Like Receptor 4 - deficiency | Cyclooxygenase 2 - genetics | Infarction, Middle Cerebral Artery - complications | Matrix Metalloproteinase 9 - genetics | Cyclooxygenase 2 Inhibitors - therapeutic use | Brain Damage, Chronic - metabolism | Interferons - genetics | Interferon Regulatory Factor-1 - biosynthesis | Encephalitis - pathology | Mice, Knockout | Toll-Like Receptor 4 - physiology | Brain Damage, Chronic - etiology | Cerebral Infarction - etiology | Brain Chemistry | Mice | Tumor Necrosis Factor-alpha - biosynthesis | Brain Damage, Chronic - prevention & control | Encephalitis - etiology | Dinoprostone - analysis | Infarction, Middle Cerebral Artery - metabolism | Cerebral Infarction - metabolism | Encephalitis - drug therapy | Nitric Oxide Synthase Type II - antagonists & inhibitors | Encephalitis - metabolism | Inflammation Mediators - metabolism | Nerve Tissue Proteins - biosynthesis | Interleukin-1beta - biosynthesis | Brain Damage, Chronic - pathology | Cerebral Infarction - pathology | Matrix Metalloproteinase 9 - biosynthesis | Mice, Inbred C57BL | Gene Expression Regulation | Infarction, Middle Cerebral Artery - pathology | Nerve Tissue Proteins - genetics | Mice, Inbred C3H | Interferon Regulatory Factor-1 - genetics | Animals | Nitric Oxide Synthase Type II - genetics | Sulfonamides - therapeutic use | Lipid Peroxidation | Nitric Oxide - metabolism | Stroke (Disease) | Complications and side effects | Patient outcomes | Physiological aspects | Development and progression | Research | Chemokines
Journal Article
Journal Article
Journal of virology, ISSN 0022-538X, 2012, Volume 86, Issue 20, pp. 10961 - 10978
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 12, p. e116142
Rationale: Replication deficient adenoviruses (Ad) vectors are common tools in gene therapy. Since Ad vectors are known to activate innate and adaptive... 
PATHOGENESIS | MATRIX | ACTIVATION | HIPPEL-LINDAU-PROTEIN | MULTIDISCIPLINARY SCIENCES | IN-VIVO | DISEASE | ANIMAL-MODELS | MEDIATED GENE-TRANSFER | IDIOPATHIC PULMONARY-FIBROSIS | EXPRESSION | Male | Interleukin-13 - biosynthesis | Lung Injury - virology | Proliferating Cell Nuclear Antigen - biosynthesis | Pulmonary Fibrosis - virology | Interleukin-16 - biosynthesis | Bronchoalveolar Lavage Fluid - cytology | Interleukin-1beta - biosynthesis | Adenoviridae - immunology | Integrins - biosynthesis | Matrix Metalloproteinase 2 - biosynthesis | Transforming Growth Factor beta1 - biosynthesis | Disease Models, Animal | Matrix Metalloproteinase 9 - biosynthesis | Actins - biosynthesis | Mice, Inbred C57BL | Inflammation - virology | Pulmonary Fibrosis - immunology | Inflammation - immunology | Bleomycin - administration & dosage | Collagen Type I - biosynthesis | Animals | Interleukin-1alpha - biosynthesis | Mice | Bronchoalveolar Lavage Fluid - chemistry | Wnt Proteins - biosynthesis | Lung Injury - immunology | RNA | Collagen | Adenoviruses | Fibrosis | Bone morphogenetic proteins | Transforming growth factors | Gene therapy | Health aspects | Integrins | Pediatrics | Collagen (type I) | Disease | Pathogenesis | Immunity | Proteins | Bleomycin | Proliferating cell nuclear antigen | Physiology | Chronic obstructive pulmonary disease | Drug dosages | Deoxyribonucleic acid--DNA | Cytokines | Bronchus | Interleukin 13 | Tumor necrosis factor-α | Gene expression | Interleukin 16 | DNA viruses | Vectors (Biology) | Pulmonary fibrosis | Interleukin 10 | Wnt protein | Laboratories | Staining | Critical care | Inflammatory response | Viruses | mRNA | Infections | Kinases | Tissues | Bronchoalveolar lavage | Rodents | Alveoli | Trachea | Injuries | Expression vectors | Lung diseases | Inflammation | Adaptive immunity | Gelatinase B | Gelatinase A | Signaling | Lungs | Molecular biology | Immunofluorescence | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2012, Volume 7, Issue 9, p. e44328
Journal Article
Medicine (Baltimore), ISSN 0025-7974, 2016, Volume 95, Issue 13, p. e3186
Journal Article